Spatial-temporal Bayesian accelerated failure time models for survival endpoints with applications to prostate cancer registry data

BMC Med Res Methodol. 2024 Apr 8;24(1):86. doi: 10.1186/s12874-024-02201-w.

Abstract

Prostate cancer is the most common cancer after non-melanoma skin cancer and the second leading cause of cancer deaths in US men. Its incidence and mortality rates vary substantially across geographical regions and over time, with large disparities by race, geographic regions (i.e., Appalachia), among others. The widely used Cox proportional hazards model is usually not applicable in such scenarios owing to the violation of the proportional hazards assumption. In this paper, we fit Bayesian accelerated failure time models for the analysis of prostate cancer survival and take dependent spatial structures and temporal information into account by incorporating random effects with multivariate conditional autoregressive priors. In particular, we relax the proportional hazards assumption, consider flexible frailty structures in space and time, and also explore strategies for handling the temporal variable. The parameter estimation and inference are based on a Monte Carlo Markov chain technique under a Bayesian framework. The deviance information criterion is used to check goodness of fit and to select the best candidate model. Extensive simulations are performed to examine and compare the performances of models in different contexts. Finally, we illustrate our approach by using the 2004-2014 Pennsylvania Prostate Cancer Registry data to explore spatial-temporal heterogeneity in overall survival and identify significant risk factors.

Keywords: Accelerated failure times; Bayesian inference; Monte Carlo Markov chain; Multivariate conditional autoregressive priors; Prostate cancer; Spatial-temporal modeling.

MeSH terms

  • Bayes Theorem
  • Humans
  • Male
  • Markov Chains
  • Models, Statistical*
  • Proportional Hazards Models
  • Prostatic Neoplasms*
  • Routinely Collected Health Data